For research use only. Not for therapeutic Use.
Bermekimab (MABp1) is a human monoclonal antibody that targets interleukin-1alpa (IL-1α). Bermekimab prevents tumour-related inflammation[1].
| Catalog Number | I042725 |
| CAS Number | 1401965-15-8 |
| Purity | ≥95% |
| Reference | [1]. McDonald JJ, et, al. Targeting IL-1α in cancer cachexia: a narrative review. Curr Opin Support Palliat Care. 2018 Dec;12(4):453-459. |
